Therapeuticsmd, INC. (TXMD) — DEF 14A Filings
All DEF 14A filings from Therapeuticsmd, INC.. Browse 2 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (2)
-
TherapeuticsMD Seeks 1,900% Share Increase, Board Re-election
— Nov 3, 2025 Risk: high
TherapeuticsMD, Inc. (TXMD) is holding its Annual Meeting of Stockholders on December 15, 2025, to address several key proposals. Shareholders will vote on the -
TherapeuticsMD Files Definitive Proxy Statement
— Oct 25, 2024 Risk: low
TherapeuticsMD, Inc. filed a Definitive Proxy Statement (DEF 14A) on October 25, 2024, for its fiscal year ending December 31, 2024. The filing, which is a prox
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX